ONEMEDNET CORPORATION Fair Value Adjustment of Warrants
ONEMEDNET CORPORATION (ONMD) reported Fair Value Adjustment of Warrants of -$31.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-14
- ONEMEDNET CORPORATION fair value adjustment of warrants for the quarter ending 2026-06-30 was -$31.00K.
- ONEMEDNET CORPORATION fair value adjustment of warrants for the quarter ending 2026-03-31 was -$16.00K, a 633.33% decline year-over-year.
- ONEMEDNET CORPORATION fair value adjustment of warrants for the quarter ending 2025-12-31 was $33.00K.
- ONEMEDNET CORPORATION fair value adjustment of warrants for the quarter ending 2025-09-30 was $20.00K, a 233.33% increase year-over-year.
- ONEMEDNET CORPORATION fair value adjustment of warrants for fiscal 2023 was -$129.00K.
- ONEMEDNET CORPORATION fair value adjustment of warrants for fiscal 2022 was -$4.49M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 5 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 8 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 11 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$31.00K 10-Q · filed 2026-08-14 | -$47.00K 10-Q · filed 2026-08-14 | -$14.00K derived: sum of 3 quarters · filed 2026-08-14 | $6.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | -$16.00K S-1/A · filed 2026-07-08 | $17.00K derived: sum of 2 quarters · filed 2026-07-08 | $37.00K derived: sum of 3 quarters · filed 2026-07-08 | $37.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $33.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $53.00K derived: sum of 2 quarters · filed 2026-07-08 | $53.00K derived: sum of 3 quarters · filed 2026-08-14 | $56.00K S-1/A · filed 2026-07-08 | ||||
| 2025-09-30 | $20.00K 10-Q · filed 2025-11-14 | $20.00K derived: sum of 2 quarters · filed 2026-08-14 | $23.00K 10-Q · filed 2025-11-14 | $9.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − S-1/A 3 month · filed 2026-08-14 | $3.00K 10-Q · filed 2026-08-14 | -$11.00K derived: sum of 3 quarters · filed 2026-08-14 | -$5.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $3.00K S-1/A · filed 2026-07-08 | -$11.00K derived: sum of 2 quarters · filed 2026-07-08 | -$5.00K derived: sum of 3 quarters · filed 2026-07-08 | $1.00K derived: sum of 4 quarters · filed 2026-07-08 | ||||
| 2024-12-31 | -$14.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | -$8.00K derived: sum of 2 quarters · filed 2026-07-08 | -$2.00K derived: sum of 3 quarters · filed 2026-07-08 | -$9.00K S-1/A · filed 2026-07-08 | ||||
| 2024-09-30 | $6.00K 10-Q · filed 2025-11-14 | $12.00K derived: sum of 2 quarters · filed 2025-11-14 | $5.00K 10-Q · filed 2025-11-14 | -$366.29K derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $6.00K 10-Q · filed 2025-08-13 | -$1.00K 10-Q · filed 2025-08-13 | -$372.29K derived: sum of 3 quarters · filed 2025-08-13 | -$130.00K derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$7.00K 10-Q · filed 2025-05-14 | -$378.29K derived: sum of 2 quarters · filed 2025-05-14 | -$136.00K derived: sum of 3 quarters · filed 2025-05-14 | |||||
| 2023-12-31 | -$371.29K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-04-15 | -$129.00K derived: sum of 2 quarters · filed 2025-04-15 | -$129.00K 10-K · filed 2025-04-15 | -$46.82K 10-K · filed 2024-04-09 | ||||
| 2023-09-30 | $242.29K 10-Q/A · filed 2023-12-18 | $242.29K 10-Q/A · filed 2023-12-18 | ||||||
| 2022-12-31 | -$245.22K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-09 | -$131.39K derived: sum of 2 quarters · filed 2024-04-09 | -$1.73M derived: sum of 3 quarters · filed 2024-04-09 | -$4.49M 10-K · filed 2024-04-09 | ||||
| 2022-09-30 | $113.83K 10-Q/A · filed 2023-12-18 | -$1.48M derived: sum of 2 quarters · filed 2023-12-18 | -$4.24M 10-Q/A · filed 2023-12-18 | |||||
| 2022-06-30 | -$1.60M 10-Q · filed 2023-08-14 | -$4.36M 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | -$2.76M 10-Q · filed 2023-05-19 | |||||||
| 2021-12-31 | -$6.33M 10-K · filed 2023-03-31 | |||||||
| 2021-09-30 | -$1.39M 10-Q · filed 2022-11-18 | -$6.39M derived: sum of 2 quarters · filed 2022-11-18 | -$6.39M 10-Q · filed 2022-11-18 | |||||
| 2021-06-30 | -$5.00M 10-Q · filed 2022-08-15 | -$5.00M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |